+99.3%
DINO vs GSK
+48.7%
+50.6%
-57.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.2% | +0.2% | -0.3% | -0.2% |
| 7D | +2.0% | -3.6% | +5.5% | +1.9% |
| 30D | +27.7% | -5.9% | +33.6% | +27.5% |
| 3M | +56.3% | -4.3% | +60.5% | +56.0% |
| 6M | +107.6% | -10.8% | +118.3% | +107.3% |
| YTD | +140.2% | +1.8% | +138.4% | +136.7% |
| 1Y | +113.0% | +23.5% | +89.5% | +106.6% |
| All | +99.3% | +48.7% | +50.6% | +89.9% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling